N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses
- PMID: 23740978
- PMCID: PMC3719814
- DOI: 10.1128/JVI.00593-13
N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses
Abstract
The hemagglutinin (HA) protein is a major virulence determinant for the 1918 pandemic influenza virus; however, it encodes no known virulence-associated determinants. In comparison to seasonal influenza viruses of lesser virulence, the 1918 H1N1 virus has fewer glycosylation sequons on the HA globular head region. Using site-directed mutagenesis, we found that a 1918 HA recombinant virus, of high virulence, could be significantly attenuated in mice by adding two additional glycosylation sites (asparagine [Asn] 71 and Asn 286) on the side of the HA head. The 1918 HA recombinant virus was further attenuated by introducing two additional glycosylation sites on the top of the HA head at Asn 142 and Asn 172. In a reciprocal experimental approach, deletion of HA glycosylation sites (Asn 142 and Asn 177, but not Asn 71 and Asn 104) from a seasonal influenza H1N1 virus, A/Solomon Islands/2006 (SI/06), led to increased virulence in mice. The addition of glycosylation sites to 1918 HA and removal of glycosylation sites from SI/06 HA imposed constraints on the theoretical structure surrounding the glycan receptor binding sites, which in turn led to distinct glycan receptor binding properties. The modification of glycosylation sites for the 1918 and SI/06 viruses also caused changes in viral antigenicity based on cross-reactive hemagglutinin inhibition antibody titers with antisera from mice infected with wild-type or glycan mutant viruses. These results demonstrate that glycosylation patterns of the 1918 and seasonal H1N1 viruses directly contribute to differences in virulence and are partially responsible for their distinct antigenicity.
Figures






Similar articles
-
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Viruses. 2014 Mar 14;6(3):1294-316. doi: 10.3390/v6031294. Viruses. 2014. PMID: 24638204 Free PMC article. Review.
-
N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.J Virol. 2020 Feb 28;94(6):e01432-19. doi: 10.1128/JVI.01432-19. Print 2020 Feb 28. J Virol. 2020. PMID: 31852790 Free PMC article.
-
Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses.Sci Transl Med. 2013 May 29;5(187):187ra70. doi: 10.1126/scitranslmed.3005996. Sci Transl Med. 2013. PMID: 23720581 Free PMC article.
-
Glycosylation on hemagglutinin affects the virulence and pathogenicity of pandemic H1N1/2009 influenza A virus in mice.PLoS One. 2013 Apr 24;8(4):e61397. doi: 10.1371/journal.pone.0061397. Print 2013. PLoS One. 2013. PMID: 23637827 Free PMC article.
-
N-linked glycosylation in the hemagglutinin of influenza A viruses.Yonsei Med J. 2012 Sep;53(5):886-93. doi: 10.3349/ymj.2012.53.5.886. Yonsei Med J. 2012. PMID: 22869469 Free PMC article. Review.
Cited by
-
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Viruses. 2014 Mar 14;6(3):1294-316. doi: 10.3390/v6031294. Viruses. 2014. PMID: 24638204 Free PMC article. Review.
-
Fusion Protein Consisting of Hemagglutinin Small Subunit and Truncated Nucleoprotein as a Universal Influenza Vaccine Candidate: Starting In-Silico Evaluation Toward In Vitro Expression.J Pharm Bioallied Sci. 2023 Jan-Mar;15(1):57-62. doi: 10.4103/jpbs.JPBS_114_18. Epub 2023 Apr 14. J Pharm Bioallied Sci. 2023. PMID: 37313538 Free PMC article.
-
State-of-the-Art Glycomics Technologies in Glycobiotechnology.Adv Biochem Eng Biotechnol. 2021;175:379-411. doi: 10.1007/10_2020_143. Adv Biochem Eng Biotechnol. 2021. PMID: 33112988
-
N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.J Virol. 2020 Feb 28;94(6):e01432-19. doi: 10.1128/JVI.01432-19. Print 2020 Feb 28. J Virol. 2020. PMID: 31852790 Free PMC article.
-
The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections.Vaccines (Basel). 2019 Nov 17;7(4):187. doi: 10.3390/vaccines7040187. Vaccines (Basel). 2019. PMID: 31744208 Free PMC article.
References
-
- Cox NJ, Subbarao K. 2000. Global epidemiology of influenza: past and present. Annu. Rev. Med. 51:407–421 - PubMed
-
- Johnson NP, Mueller J. 2002. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull. Hist. Med. 76:105–115 - PubMed
-
- Zimmer SM, Burke DS. 2009. Historical perspective—emergence of influenza A (H1N1) viruses. N. Engl. J. Med. 361:279–285 - PubMed
-
- Maurizi CP. 1985. Why was the 1918 influenza pandemic so lethal? The possible role of a neurovirulent neuraminidase. Med. Hypotheses 16:1–5 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources